The low-dose irradiation induces expression of IL-17 in tumor beds and enhances the growth of subsequently implanted tumor cells, while treatment with anti-IL-17 antibody abolished the acceleration of tumor growth, confirming the key role of IL-17 in enhancing tumor growth in pre-irradiated tumor beds [170]. The gene discussed is IL17A; the disease is neoplasm.